{"id":3030,"date":"2022-05-23T12:26:21","date_gmt":"2022-05-23T16:26:21","guid":{"rendered":"https:\/\/sites.bu.edu\/tpri\/?page_id=3030"},"modified":"2023-05-15T14:00:14","modified_gmt":"2023-05-15T18:00:14","slug":"ip-day-2022","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/tpri\/news-and-events\/ip-day-2022\/","title":{"rendered":"IP Day 2022"},"content":{"rendered":"<h4><img loading=\"lazy\" src=\"\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01-636x318.png\" alt=\"TPRI IP Day 2022\" width=\"636\" height=\"318\" class=\"aligncenter wp-image-3084 size-medium\" srcset=\"https:\/\/sites.bu.edu\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01-636x318.png 636w, https:\/\/sites.bu.edu\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01-1024x512.png 1024w, https:\/\/sites.bu.edu\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01-768x384.png 768w, https:\/\/sites.bu.edu\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01-1536x768.png 1536w, https:\/\/sites.bu.edu\/tpri\/files\/2022\/06\/22066-TPRI-IPDay-WebImage-003-01.png 1875w\" sizes=\"(max-width: 636px) 100vw, 636px\" \/><\/h4>\n<p><a href=\"https:\/\/cvent.me\/Y1g5nE\" target=\"_blank\" rel=\"noopener noreferrer\">\u00a0<\/a><\/p>\n<h4 style=\"text-align: center;\">Friday,\u00a0July 22, 2022<br \/>\nHosted by TPRI<\/h4>\n<p style=\"text-align: left;\">The Sixth Annual Boston University Technology &amp; Policy Research Initiative IP Day conference focuses on two main themes: (1) The impact of patents on pharmaceutical innovation, and (2) Policy interactions of patent, trade secret, trademark, and antitrust law as applied to innovation. Pharma-sector presenters will discuss how patent policy affects global access to medicine, as well as the impacts of intellectual property policy on the strategies of pharmaceutical firms within the U.S. Other presenters will cover a variety of topics including the choice of trade secret or patent protection to appropriate value from innovation, and the use of antitrust law to limit the strength and scope of intellectual property rights.<\/p>\n<h4 style=\"text-align: center;\">Agenda<br \/>\nFriday, July 22<br \/>\n(All times Eastern Daylight Time)<\/h4>\n<h4><\/h4>\n<p>&nbsp;<\/p>\n<h4 style=\"text-align: left;\">Registration and Breakfast (8-8:45AM)<\/h4>\n<p>&nbsp;<\/p>\n<h4>Introduction and Welcome to IP Day 2022 (8.45 \u2013 09.00 AM)<\/h4>\n<p>&nbsp;<\/p>\n<h4>Panel 1: International Pharma (9-10:30 AM) (<a href=\"https:\/\/mymedia.bu.edu\/media\/t\/1_usgoqtjc\" target=\"_blank\" rel=\"noopener noreferrer\">video<\/a>)<\/h4>\n<p>Iain Cockburn, Tim Wilsdon, Michele Pistollato, Rajini Jayasuriya, and Thomas Watson, \u00a0\u201c<a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=3990215\" target=\"_blank\" rel=\"noopener noreferrer\">The role of TRIPS in encouraging pharmaceutical technological diffusion in developing countries<\/a>\u201d<\/p>\n<p>Alberto Galasso and Mark Schankerman, \u201c<a href=\"https:\/\/www.nber.org\/system\/files\/working_papers\/w28545\/w28545.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool<\/a>\u201d<\/p>\n<p>Discussant: Arti Rai<\/p>\n<p>&nbsp;<\/p>\n<h4>Coffee Break (10:30-11:00 AM)<\/h4>\n<p>&nbsp;<\/p>\n<h4>Panel 2: Settlements (11-12:00 PM) (<a href=\"https:\/\/mymedia.bu.edu\/media\/t\/1_tzvog4nj\" target=\"_blank\" rel=\"noopener noreferrer\">video<\/a>)<\/h4>\n<p>Xuelin Li, Andrew W. Lo and Richard T. Thakor, \u00a0&#8220;<a href=\"https:\/\/www.nber.org\/papers\/w28964\" target=\"_blank\" rel=\"noopener noreferrer\">Paying Off The Competition: Market Power And Innovation Incentives.<\/a>&#8221;<\/p>\n<p>C. Scott Hemphill and Erik Hovenkamp ,\u201c<a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4028144\" target=\"_blank\" rel=\"noopener noreferrer\">Antitrust and Trademark Settlements.<\/a>\u201d<\/p>\n<p>Discussant: Michael Meurer<\/p>\n<p>&nbsp;<\/p>\n<h4>Lunch Panel Discussion on\u00a0What did Covid teach us about IP and Pharma?\u00a0(12-1:30PM) (<a href=\"https:\/\/mymedia.bu.edu\/media\/t\/1_pncg15bh\" target=\"_blank\" rel=\"noopener noreferrer\">video<\/a>)<\/h4>\n<p>Panelists: Rena Conti, Jorge L. Contreras, Shanelle Hall, Kevin Outterson, and\u00a0Arti Rai<\/p>\n<p>&nbsp;<\/p>\n<h4>Panel 3: Trade Secrets, Patents and Appropriability (1:30-3:00 PM) (<a href=\"https:\/\/mymedia.bu.edu\/media\/t\/1_o3ijvkh2\" target=\"_blank\" rel=\"noopener noreferrer\">video<\/a>)<\/h4>\n<p>Colleen Cunningham and Aldona Kapa\u010dinskait\u0117, \u201cKeeping invention confidential: The role of strengthened appropriability in the use of trade secrets.\u201d<\/p>\n<p>Tim Simcoe and Filippo Mezzanotti, \u201c<a href=\"https:\/\/www.census.gov\/library\/working-papers\/2022\/adrm\/CES-WP-22-09.html\" target=\"_blank\" rel=\"noopener noreferrer\">Innovation and Appropriability: Revisiting the Role of Intellectual Property.<\/a>\u201d<\/p>\n<p>Mark A. Lemley and Samantha Zyontz,\u00a0\u201c<a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=3561252\" target=\"_blank\" rel=\"noopener noreferrer\">Does Alice Target Patent Trolls.<\/a>\u201d<\/p>\n<p>Discussant: Hong Luo<\/p>\n<p>&nbsp;<\/p>\n<h4>Coffee Break (3-3:30PM)<\/h4>\n<p>&nbsp;<\/p>\n<h4>Panel 4: Patent Policy Instruments (3:30-4:30 PM) (<a href=\"https:\/\/mymedia.bu.edu\/media\/t\/1_lkhan1z6\" target=\"_blank\" rel=\"noopener noreferrer\">video<\/a>)<\/h4>\n<p>Michael D. Frakes and Melissa F. Wasserman,\u00a0\u201c<a href=\"https:\/\/www.nber.org\/papers\/w27579\" target=\"_blank\" rel=\"noopener noreferrer\">Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination.<\/a>\u201d<\/p>\n<p>Laura G. Pedraza-Fari\u00f1a and Ryan Whalen,\u00a0 <a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4071208\" target=\"_blank\" rel=\"noopener noreferrer\">The Ghost in the Patent System: An Empirical Study of Patent Law\u2019s Elusive \u201cOrdinary Artisan<\/a>.\u201d<\/p>\n<p>Discussant: Timothy Simcoe<\/p>\n<p>&nbsp;<\/p>\n<h4>Closing Remarks and Reception (4:30-5:45 PM)<\/h4>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 Friday,\u00a0July 22, 2022 Hosted by TPRI The Sixth Annual Boston University Technology &amp; Policy Research Initiative IP Day conference focuses on two main themes: (1) The impact of patents on pharmaceutical innovation, and (2) Policy interactions of patent, trade secret, trademark, and antitrust law as applied to innovation. Pharma-sector presenters will discuss how patent [&hellip;]<\/p>\n","protected":false},"author":13705,"featured_media":0,"parent":23,"menu_order":9,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/pages\/3030"}],"collection":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/users\/13705"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/comments?post=3030"}],"version-history":[{"count":48,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/pages\/3030\/revisions"}],"predecessor-version":[{"id":3301,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/pages\/3030\/revisions\/3301"}],"up":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/pages\/23"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/tpri\/wp-json\/wp\/v2\/media?parent=3030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}